Literature DB >> 4018178

Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients.

J Banks, C Bevan, A Fennerty, P Ebden, E H Walters, A P Smith.   

Abstract

Nineteen stable asthmatic patients were given killed influenza virus intramuscularly. In 9 patients who developed a fourfold or greater rise in haemagglutination antibodies, an increase in airway sensitivity to histamine was demonstrated 48 h later. There was no significant change in histamine sensitivity in those patients who failed to develop a fourfold rise in haemagglutination antibodies. The increased histamine sensitivity was not associated with a deterioration in asthma symptoms, peak expiratory flow, nor an increase in bronchodilator requirements.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018178

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  6 in total

Review 1.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 2.  Humoral immune response to influenza vaccination in patients from high risk groups.

Authors:  L B Brydak; M Machala
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

3.  Influenza vaccination in asthma: a primary care experience.

Authors:  A Innes; E Beresford; J Bedford
Journal:  Br J Gen Pract       Date:  2000-01       Impact factor: 5.386

Review 4.  Does influenza vaccination exacerbate asthma?

Authors:  C L Park; A Frank
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

5.  Influenza vaccination in patients with asthma: effect on peak expiratory flow, asthma symptoms and use of medication.

Authors:  A H Ahmed; K G Nicholson; V S Hammersley; J Kent
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

6.  Effect of influenza vaccinations on immune response and serum eotaxin level in patients with allergic bronchial asthma.

Authors:  Karina Jahnz-Rózyk; Lidia B Brydak; Tomasz Targowski; Magdalena Machała; Tadeusz Plusa
Journal:  Mediators Inflamm       Date:  2004-06       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.